Omega Fund Management as of March 31, 2020
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 16 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Replimune Group (REPL) | 21.9 | $53M | 5.3M | 9.92 | |
| Morphic Hldg (MORF) | 18.0 | $44M | 3.0M | 14.68 | |
| Gossamer Bio (GOSS) | 18.0 | $43M | 4.3M | 10.15 | |
| Arcutis Biotherapeutics (ARQT) | 10.4 | $25M | 845k | 29.80 | |
| Translate Bio | 10.1 | $24M | 2.4M | 9.97 | |
| Immunic (IMUX) | 3.4 | $8.3M | 1.4M | 6.05 | |
| Paratek Pharmaceuticals | 3.4 | $8.2M | 2.6M | 3.15 | |
| Essa Pharma (EPIX) | 2.8 | $6.8M | 1.7M | 4.00 | |
| Beam Therapeutics (BEAM) | 2.3 | $5.5M | 303k | 18.00 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 2.1 | $5.0M | 2.0M | 2.48 | |
| Fibrogen (FGEN) | 1.9 | $4.5M | 131k | 34.75 | |
| Trevi Therapeutics (TRVI) | 1.7 | $4.2M | 1.3M | 3.29 | |
| Prevail Therapeutics Ord | 1.4 | $3.3M | 273k | 12.19 | |
| Jounce Therapeutics | 1.0 | $2.5M | 530k | 4.75 | |
| Obseva Sa | 1.0 | $2.4M | 999k | 2.41 | |
| Pieris Pharmaceuticals | 0.7 | $1.7M | 751k | 2.28 |
